June 29, 2021 - 1:00pm
Microsoft Office Teams Live
Due to the COVID-19 pandemic, this meeting will be conducted online using Microsoft Teams only. Join the meeting here.
Closed captioning for this meeting is available. Viewers are asked to highlight the closed captioning symbol "cc" on the bottom of their viewing screen to enable this function.
There is not a physical location for this meeting.
Attendees who would like to provide public comment should see the Public Comment section below.
- Call to Order & Welcome Remarks - DSHS Commissioner John Hellerstedt, M.D.
- Approval of Meeting Minutes from April 13, 2021 - Task Force Members
- COVID-19 Situation Update - DSHS Commissioner John Hellerstedt, M.D.
- COVID-19 Legislative Update - Donna Sheppard
- COVID-19 Vaccine Update - Saroj Rai, Ph.D.
- COVID-19 Vaccine Distribution Plan Update - Imelda Garcia, MPH
- Public Comment
- Planning and Discussion of Future Meeting Topics - Task Force Members
- Adjourn - DSHS Commissioner John Hellerstedt, M.D.
The Task Force may take any action on any agenda item.
Public Comment: DSHS welcomes public comments pertaining to topics related to the Task Force on Infectious Disease. Members of the public who would like to provide public comment are asked to complete a Public Comment form here.
Members of the public who would like to provide written public comment to DSHS may email Adesuwa Ebomwonyi , Laboratory and Infectious Disease Services Division, DSHS; at TaskForceID@dshs.texas.gov no later than 5:00 p.m. Friday, June 25, 2021. Please include your name and the organization you are representing, or that you are speaking as a private citizen. Staff will not read written comments aloud during the meeting, but comments will be forwarded to State staff and members for their consideration. Comments should not include confidential information or protected health information.
If you would like to register to provide oral comments, please mark the correct box on the Public Comment form. Instructions for providing oral comment will be emailed to you. Registration should be completed no later than 5:00 p.m. Friday, June 25, 2021. Members of the public may also use the Microsoft Teams Live Event Q&A section during the meeting to submit a request to provide public comment. The request must contain your name, either the name of the organization you are representing or that you are speaking as a private citizen, and your direct phone number. Do not include confidential information or protected health information in comments.
Public comment is limited to three minutes. Each speaker must state their name and either the organization they are representing or that they are speaking as a private citizen. Public members who are using handouts are asked to provide an electronic copy in accessible PDF format. Handouts are limited to two pages (paper size: 8.5” by 11”, one side only). Handouts must be emailed to HHSC immediately after registering and include the name of the person who will be commenting. Do not include confidential information or protected health information in handouts. Staff will not read handouts aloud during the meeting, but handouts will be provided to members and State staff. It is not permissible for public speakers to interject or ask questions to members during the rest of the meeting.
Contact: Questions regarding agenda items, content, or meeting arrangements should be directed to: Adesuwa Ebomwonyi, Laboratory and Infectious Disease Services Division, DSHS; Phone: (512)969-0428, E-mail: TaskForceID@dshs.texas.gov.
This meeting is open to the public. No reservations are required, and there is no cost to attend this meeting.
People with disabilities who wish to attend the meeting and require auxiliary aids or services should contact Adesuwa Ebomwonyi, DSHS, at (512)969-0428 or TaskForceID@dshs.texas.gov at least 72 hours prior to the meeting so that appropriate arrangements may be made